1. Home
  2. AGEN vs ACRE Comparison

AGEN vs ACRE Comparison

Compare AGEN & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$5.00

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Logo Ares Commercial Real Estate Corporation

ACRE

Ares Commercial Real Estate Corporation

HOLD

Current Price

$4.61

Market Cap

245.8M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
ACRE
Founded
1994
2011
Country
United States
United States
Employees
81
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
208.2M
245.8M
IPO Year
1999
2011

Fundamental Metrics

Financial Performance
Metric
AGEN
ACRE
Price
$5.00
$4.61
Analyst Decision
Buy
Hold
Analyst Count
2
4
Target Price
$14.50
$5.38
AVG Volume (30 Days)
8.0M
475.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
11.58%
EPS Growth
100.00
26.17
EPS
1.02
1.35
Revenue
$42,877,086.00
$54,833,000.00
Revenue This Year
$107.63
N/A
Revenue Next Year
N/A
$16.28
P/E Ratio
$4.95
$3.47
Revenue Growth
89.95
N/A
52 Week Low
$2.71
$4.05
52 Week High
$8.70
$5.89

Technical Indicators

Market Signals
Indicator
AGEN
ACRE
Relative Strength Index (RSI) 65.37 50.84
Support Level $3.16 $4.33
Resistance Level N/A $4.73
Average True Range (ATR) 0.63 0.13
MACD 0.21 0.04
Stochastic Oscillator 35.63 77.33

Price Performance

Historical Comparison
AGEN
ACRE

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

About ACRE Ares Commercial Real Estate Corporation

Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.

Share on Social Networks: